Showing results (1791-1800 of 1,951) with videos related to

Sort By:
Pageof 196
AEM Education and Training|February 23, 2026
Trauma Training for Emergency Department Physicians in Low- and Middle-Income Countries: A Scoping ReviewJill B Nelson, Rebecca Soistmann, Ana M Reyes, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|February 17, 2022
Decreasing delivery room CPAP-associated pneumothorax at ≥35-week gestational ageEdward F Stocks, Mambarambath Jaleel, William Smithhart, et al.
The New England Journal of Medicine|September 26, 1996
Complications of endoscopic biliary sphincterotomyM L Freeman, D B Nelson, S Sherman, et al.
Plos Pathogens|May 23, 2013
Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A)Birgitte P S Jacky, Patton E Garay, Jérôme Dupuy, et al.
Translational Psychiatry|May 2, 2013
Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosisC A Bousman, A R Yung, C Pantelis, et al.
Journal of the American Geriatrics Society|April 21, 2020
Validation of the Risk Analysis Index for Evaluating Frailty in Ambulatory PatientsRupen Shah, Jeffrey D Borrebach, Jacob C Hodges, et al.
Gastroenterology|March 1, 2017
MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in MiceZhang-Hui Chen, Yan P Yu, Junyan Tao, et al.
Endocrinology|May 15, 2013
5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal modelsKhalid Z Masoodi, Raquel Ramos Garcia, Laura E Pascal, et al.
Epidemiology and Psychiatric Sciences|May 28, 2021
Stress reactivity as a putative mechanism linking childhood trauma with clinical outcomes in individuals at ultra-high-risk for psychosis: Findings from the EU-GEI High Risk StudyI Paetzold, I Myin-Germeys, A Schick, et al.
Endocrinology|October 5, 2017
Inhibition of Androgen Receptor Function and Level in Castration-Resistant Prostate Cancer Cells by 2-[(isoxazol-4-ylmethyl)thio]-1-(4-phenylpiperazin-1-yl)ethanoneKhalid Z Masoodi, Kurtis Eisermann, Zhenyu Yang, et al.
Pageof 196